Description
KB-0742 dihydrochloride is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 dihydrochloride is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2416874-75-2 |
|---|---|
| Purity | ≥99% |
| Formula | C16H25N5 • 2HCl |
| Formula Wt. | 360.32 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine dihydrochloride |
| Synonym | KB0742 dihydrochloride, NSC-834161 dihydrochloride, NSC834161 dihydrochloride |
| Appearance | Yellow crystal powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Induces ER degradation.
Polyphenol found in Camilla sinensis; HIV integ...
COMT inhibitor.
Zinc chelator
Protein translation inhibitor, peptidyl transfe...
DPP4 inhibitor.
Mycotoxin produced by Aspergillus; actin polyme...
14-α demethylase inhibitor.
Mycotoxin produced by Aspergillus; BK K+ channe...
Anthracycline, DNA intercalator; topoisomerase ...
Imidazoline derivative; α1-adrenergic agonist,...
p38 MAPK inhibitor.
OVA antigen.
Building block
Cathelicidin derivative, antimicrobial peptide,...
KRAS inhibitor
EGFR inhibitor.
Thiazolidine; Pim kinase inhibitor.
Inhibitor of ATM.
5-Lipoxygenase inhibitor.